Invited Commentary: Tolerability, Attrition Rates, and Survival Outcomes of Neoadjuvant FOLFIRINOX for Nonmetastatic Pancreatic Adenocarcinoma: Intent-to-Treat Analysis.

Autor: Clancy, Thomas E
Zdroj: Journal of the American College of Surgeons (2563-9021); Jun2023, Vol. 236 Issue 6, p1136-1138, 3p
Databáze: Complementary Index